Primary Children's Hospital

Futó vizsgálatok

• Toboroz

  A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

  NCT07621614· 2. fázis· Children's Oncology Group· Forrás

• Toboroz

  A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

  NCT07466316· 3. fázis· Children's Oncology Group· Forrás

• Toboroz

  A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study

  NCT07525843· Carelon Research· Forrás

• Toboroz

  Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

  NCT07194044· 1. fázis· H. Lee Moffitt Cancer Center and Research Institute· Forrás

• Toboroz

  Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

  NCT06579469· St. Jude Children's Research Hospital· Forrás

• Fut, nem toboroz

  A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

  NCT07107945· 3. fázis· Boehringer Ingelheim· Forrás

• Fut, nem toboroz

  A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

  NCT06872125· 3. fázis· Stoke Therapeutics, Inc· Forrás

• Toboroz

  A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  NCT06124157· 2. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

  NCT06401330· 3. fázis· Children's Oncology Group· Forrás

• Toboroz

  Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

  NCT06647953· 3. fázis· Children's Oncology Group· Forrás

• Toboroz

  52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism

  NCT06689085· 3. fázis· Halozyme Therapeutics· Forrás

• Meghívásos bevonás

  Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0

  NCT06823115· Indiana University· Forrás

• Fut, nem toboroz

  A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases

  NCT06255028· 1. fázis· Century Therapeutics, Inc.· Forrás

• Toboroz

  Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  NCT06541262· 1/2. fázis· Milton S. Hershey Medical Center· Forrás

• Toboroz

  A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

  NCT06368817· 2. fázis· Children's Oncology Group· Forrás

• Toboroz

  A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

  NCT05849662· 1/2. fázis· Therapeutic Advances in Childhood Leukemia Consortium· Forrás

• Toboroz

  A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

  NCT05711667· 3. fázis· Children's Oncology Group· Forrás

• Toboroz

  Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  NCT06172296· 3. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer

  NCT05958316· Virginia Commonwealth University· Forrás

• Toboroz

  RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

  NCT06154252· 2/3. fázis· Cabaletta Bio· Forrás

• Toboroz

  Cord Clamping Among Neonates With Congenital Heart Disease

  NCT06153459· Carl Backes, MD· Forrás

• Toboroz

  A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

  NCT06173518· 1. fázis· Autolus Limited· Forrás

• Fut, nem toboroz

  Expanded Indications in the Pediatric BONEBRIDGE Population

  NCT05615649· Med-El Corporation· Forrás

• Meghívásos bevonás

  CHAMP App Cardiac Study and Repository

  NCT06034392· Lori Erickson· Forrás

• Toboroz

  A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

  NCT05675410· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome

  NCT05457556· 3. fázis· Children's Oncology Group· Forrás

• Toboroz

  Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

  NCT05535166· 2. fázis· St. Jude Children's Research Hospital· Forrás

• Toboroz

  Duchenne Electronic Health Record Study

  NCT07609394· The Duchenne Registry· Forrás

• Fut, nem toboroz

  Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors

  NCT05286801· 1/2. fázis· National Cancer Institute (NCI)· Forrás

• Meghívásos bevonás

  EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study

  NCT05610787· Berlin Heart, Inc· Forrás

• Toboroz

  A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue

  NCT05634369· 1/2. fázis· Nationwide Children's Hospital· Forrás

• Toboroz

  Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  NCT05476770· 1. fázis· Therapeutic Advances in Childhood Leukemia Consortium· Forrás

• Fut, nem toboroz

  Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

  NCT05183035· 3. fázis· PedAL BCU, LLC· Forrás

• Toboroz

  A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)

  NCT05201144· 2. fázis· University of Utah· Forrás

• Toboroz

  Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

  NCT05304585· 3. fázis· Children's Oncology Group· Forrás

• Toboroz

  A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

  NCT05135975· 2. fázis· Nationwide Children's Hospital· Forrás

• Fut, nem toboroz

  Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

  NCT05268094· Carelon Research· Forrás

• Fut, nem toboroz

  A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

  NCT05099003· 1/2. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  ALTERRA Post-Approval Study

  NCT05378386· Edwards Lifesciences· Forrás

• Fut, nem toboroz

  A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor

  NCT04939597· 3. fázis· Children's Oncology Group· Forrás

• Toboroz

  The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  NCT04726241· 1/2. fázis· PedAL BCU, LLC· Forrás

• Toboroz

  Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

  NCT05235165· 3. fázis· Children's Oncology Group· Forrás

• Toboroz

  Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

  NCT05082519· 2. fázis· Etan Orgel· Forrás

• Toboroz

  CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

  NCT04870944· 1/2. fázis· Children's Oncology Group· Forrás

• Fut, nem toboroz

  Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma

  NCT04759586· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma

  NCT04994132· 3. fázis· Children's Oncology Group· Forrás

• Toboroz

  A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

  NCT04684368· 2. fázis· Children's Oncology Group· Forrás

• Fut, nem toboroz

  Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

  NCT04320888· 2. fázis· National Cancer Institute (NCI)· Forrás

• Toboroz

  Childhood Cancer Predisposition Study (CCPS)

  NCT04511806· Emory University· Forrás

• Toboroz

  VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems

  NCT03953768· University of Louisville· Forrás

Showing 50 of 100.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok34 toboroz
• Akut limfoid leukémia (ALL)8 toboroz
• Szarkóma7 toboroz
• Congenital heart disease5 toboroz
• Neuroblasztóma4 toboroz
• Akut mieloid leukémia (AML)3 toboroz
• Vesedaganat3 toboroz
• Down syndrome2 toboroz
• Hodgkin-limfóma2 toboroz
• Magas vérnyomás2 toboroz
• Mielodiszplasztikus szindróma (MDS)2 toboroz
• Neurofibromatosis type 12 toboroz
• Charcot-Marie-Tooth disease1 toboroz
• Cytomegalovirus infection1 toboroz
• Dermatomyositis and polymyositis (myositis)1 toboroz
• Duchenne-izomdisztrófia1 toboroz
• Elhízás1 toboroz
• Epilepszia1 toboroz
• Hydrocephalus1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Krónikus vesebetegség1 toboroz
• Male hypogonadism1 toboroz
• Melanóma1 toboroz
• Mieloproliferatív neopláziák1 toboroz
• Neuroendokrin daganatok1 toboroz
• Pulmonális artériás hipertónia1 toboroz
• Sjögren-szindróma1 toboroz
• Szívelégtelenség1 toboroz
• Tüdőrák1 toboroz

Lezárt vizsgálatok

• Leállították

  A Study to Understand the Long-term Safety and Effects of an Experimental Gene Therapy for Duchenne Muscular Dystrophy.

  NCT05689164· 3. fázis· Pfizer· Forrás

• Leállították

  A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)

  NCT05600426· 3. fázis· Boston Children's Hospital· Forrás

• Toboroz

  A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

  NCT04782258· 3. fázis· Otsuka Pharmaceutical Development & Commercialization, Inc.· Forrás

• Toboroz

  A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

  NCT05504291· 2. fázis· Children's Oncology Group· Forrás

• Leállították

  Study of Fordadistrogene Movaparvovec in Early Stage Duchenne Muscular Dystrophy

  NCT05429372· 2. fázis· Pfizer· Forrás

• Lezárult

  Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)

  NCT05312177· Carelon Research· Forrás

• Leállították

  A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome

  NCT05163314· 3. fázis· Takeda· Forrás

• Lezárult

  Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior

  NCT05767385· 2/3. fázis· University of Utah· Forrás

• Lezárult

  A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome

  NCT04938427· 3. fázis· Takeda· Forrás

• Lezárult

  An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome

  NCT04442295· 1/2. fázis· Stoke Therapeutics, Inc· Forrás

• Lezárult

  Precision Guided Tacrolimus Dosing in Pediatric Heart Transplant

  NCT04380311· University of Utah· Forrás

• Lezárult

  Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

  NCT03786783· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)

  NCT03790332· 1/2. fázis· Pharmacyclics LLC.· Forrás

• Lezárult

  Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures

  NCT03678753· 3. fázis· SK Life Science, Inc.· Forrás

• Lezárult

  Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

  NCT03526250· 2. fázis· National Cancer Institute (NCI)· Forrás

• Leállították

  A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy

  NCT03362502· 1. fázis· Pfizer· Forrás

• Lezárult

  Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)

  NCT03213678· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)

  NCT03213665· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

  NCT03220035· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)

  NCT03213691· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

  NCT03233204· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement

  NCT02828358· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment

  NCT02927769· 2. fázis· Bristol-Myers Squibb· Forrás

• Lezárult

  Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy

  NCT02879643· 1. fázis· Therapeutic Advances in Childhood Leukemia Consortium· Forrás

• Lezárult

  A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia

  NCT02723994· 2. fázis· Incyte Corporation· Forrás

• Lezárult

  Apixaban for the Acute Treatment of Venous Thromboembolism in Children

  NCT02464969· 4. fázis· Bristol-Myers Squibb· Forrás

• Lezárult

  Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma

  NCT02470091· 2. fázis· Children's Oncology Group· Forrás

• Lezárult

  A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia A

  NCT02615691· 3. fázis· Baxalta now part of Shire· Forrás

• Lezárult

  Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

  NCT02180867· 2/3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Molecular-Guided Therapy for Childhood Cancer

  NCT02162732· Giselle Sholler· Forrás

• Lezárult

  Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma

  NCT01979536· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer

  NCT01802567· Giselle Sholler· Forrás

• Lezárult

  Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma

  NCT01553149· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors

  NCT01602666· 2. fázis· Children's Oncology Group· Forrás

• Lezárult

  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations

  NCT02883049· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

  NCT01175356· 1. fázis· Children's Oncology Group· Forrás

• Lezárult

  Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

  NCT01371981· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma

  NCT01236560· 2/3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma

  NCT01231906· 3. fázis· Children's Oncology Group· Forrás

• Lezárult

  Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma

  NCT01190930· 3. fázis· Children's Oncology Group· Forrás

• Lezárult

  Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

  NCT01096368· 3. fázis· Children's Oncology Group· Forrás

• Lezárult

  Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

  NCT00980460· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor

  NCT00945009· 3. fázis· Children's Oncology Group· Forrás

• Lezárult

  Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System

  NCT00653068· 3. fázis· Children's Oncology Group· Forrás

• Lezárult

  Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

  NCT00557193· 3. fázis· Children's Oncology Group· Forrás

• Lezárult

  Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma

  NCT00336024· 3. fázis· Children's Oncology Group· Forrás

• Lezárult

  Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET

  NCT00392327· 3. fázis· Children's Oncology Group· Forrás

• Lezárult

  Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor

  NCT00379340· 3. fázis· Children's Oncology Group· Forrás

• Lezárult

  Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

  NCT00408005· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor

  NCT00352534· 3. fázis· Children's Oncology Group· Forrás

Showing 50 of 56.